Interest in astroglial cells is rising due to recent findings supporting dynamic neuron-astrocyte interactions. There is increasing evidence of astrocytic dysfunction in several brain disorders such as depression, schizophrenia or bipolar disorder; importantly these pathologies are characterized by the involvement of the prefrontal cortex and by significant cognitive impairments. Here, to model astrocyte pathology, we injected animals with the astrocyte specific toxin L-α-aminoadipate (L-AA) in the medial prefrontal cortex (mPFC); a behavioral and structural characterization two and six days after the injection was performed. Behavioral data shows that the astrocyte pathology in the mPFC affects the attentional set-shifting, the working memory and the reversal learning functions. Histological analysis of brain sections of the L-AA-injected animals revealed a pronounced loss of astrocytes in the targeted region. Interestingly, analysis of neurons in the lesion sites showed a progressive neuronal loss that was accompanied with dendritic atrophy in the surviving neurons. These results suggest that the L-AA-induced astrocytic loss in the mPFC triggers subsequent neuronal damage leading to cognitive impairment in tasks depending on the integrity of this brain region. These findings are of relevance to better understand the pathophysiological mechanisms underlying disorders that involve astrocytic loss/dysfunction in the PFC.
INTRODUCTION
The knowledge of the nervous system has evolved rapidly in the last decades, namely due to the disclosure of more prominent role of astrocytes in physiological and pathological processes. Among glial cells, astrocytes were pointed out as neuronal partners since they keep a concerted cross-talk with vicinal neurons, which is crucial for normal brain function. Astrocytes are able to sense neuronal activity by expressing an extensive number of neurotransmitter receptors, which lead to both homeostatic changes and cellular cross-talk. 1, 2 The astrocytic homeostatic responses include alterations of metabolic activity, synthesis of neuronal preferred energy substrate lactate, clearance of neurotransmitters and buffering of extracellular K + ions. 1, 3, 4 With respect to the alterations of cellular cross-talk, a bidirectional communication between neurons and astrocytes, conceptualized as the tripartite synapse, [5] [6] [7] was extensively demonstrated both in brain slice preparations [8] [9] [10] [11] [12] [13] [14] [15] [16] and in vivo [17] [18] [19] [20] [21] [22] [23] [24] in rodents and, more recently, in humans. 25 Taking these evidences into account, it is expected that changes in astrocyte number and/or function would impact on the neuron-astrocyte network integrity and activity and, consequently, on behavior output. Indeed, a large set of evidence has pointed out an important pathological role of astrocytic dysfunction in several conditions. [26] [27] [28] In particular, specific astrocytic markers such as the glial fibrilary acidic protein (GFAP) or glutamine synthetase were shown to be decreased in the context of brain disorders such as depression, schizophrenia or bipolar disorder, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] consisting a state of astrocyte pathology possibly having a role on its pathophysiology. [41] [42] [43] [44] Amongst the most affected brain regions is the prefrontal cortex (PFC), 26, 30, 32, 34 which is implicated in attentional processes, decision-making, goaldirected behavior, working memory, processing of emotional stimuli, temporal organization of behavior, rule learning and behavior flexibility. [45] [46] [47] [48] Furthermore, the medial prefrontal cortex (mPFC) is anatomically and functionally linked with other components of the limbic system, which justifies the key role in cognitive, mnesic and emotional processing. 49, 50 Accordingly, astrocyte loss in the PFC is sufficient to induce depression-like behavior in the rat [51] [52] [53] and blockade of astrocytic glutamate uptake in this region is also sufficient to produce anhedonia, a hallmark of depression. 54 Although these observations may also justify the cognitive dysfunction observed in patients suffering mood disorders the impact of astrocyte loss in the mPFC, and consecutively on mPFCdependent cognitive function is still poorly understood. In order to tackle this question, we induced an astrocyte pathology state in the mPFC by injection of the specific astrocyte toxin L-aminoadipate and assessed cognitive function of the treated animals by testing their performance in working memory, behavior flexibility, attention and reference memory tasks, as well as by characterizing the structural consequences of astrocytic loss in the mPFC.
MATERIALS AND METHODS

Animals and treatments
Experiments were conducted in accordance with local regulations (European Union Directive 86/609/EEC) and National Institutes of Health guidelines on animal care and experimentation. Male Wistar-Han rats (Charles River Laboratories, Barcelona, Spain), ten-weeks-old, were housed in groups of two, under standard laboratory conditions (room temperature 22°C; food and water ad libitum; 12 h dark/light cycle, lights on at 08:00). The astrocyte pathology model was obtained by the intracranial injection of the selective toxin L-α-aminoadipate (L-AA) 55 in treated animals. The two groups of animals used for experimentation, control (CON) and treated (AA), were obtained by a single bilateral microinjection of artificial cerebrospinal fluid (aCSF) or L-AA, respectively, in the mPFC. In order to avoid interference of the injection surgical procedures with the behavior performance, cannula guides were surgically implanted in all animals one week prior to the microinjection. The injections took place one day before the start of the experiment through the implanted cannulas with minor impact to the animal. Detailed surgical and injection procedures are given in SI.
Behavioral testing
The consequences of the induced astrocyte pathology in the mPFC to the cognitive function of CON and AA animals were assessed in the attentional set-shifting task (ASST) and in water maze tests. Animals of CON and AA groups were divided into two sub-sets. The first sub-set performed two days of ASST and the second sub-set performed six days of water maze tests. Therefore, the tests were performed within the effect window of the toxin previously described. 55 The ASST was used to assess the non-spatial working memory, the attentional set-shifting and the reversal learning functions of rats based on previously described protocols. 56 Briefly, the test was conducted in a rectangular arena (black Plexiglass; 60 cm × 40 cm × 20 cm) where animals were required to dig and find a reward (Nestlé Cheerios® cut in two) in one of two bowls filled with sawdust. The reward was related to the presence of relevant odor or texture stimuli that were randomly exchanged (for test scheme, Figure 1a ; Supplementary Table S1), being the criterion accomplished whenever six consecutive correct responses were achieved for each stage.
Water maze tests were used to assess the performance of experimental animals in spatial working and reference memory tasks as described previously. 57, 58 Briefly, these tests were conducted in a circular black pool (170 cm diameter) filled with water at 22°C to a depth of 34 cm in a room with extrinsic clues (triangle, square, cross and horizontal stripes) and dim light. An invisible platform was placed in one of four quadrants as observed in Figures 2a and d . In the working memory task (WMT), animals had to learn the location of the hidden platform and to retain this information online during the four consecutive trials since the platform was placed in a different position each day. In the reference memory task (RMT), the platform position was unchanged. Distances swam and escape latencies to platform were used as readout of task performance. Details on the behavior tasks are given in SI. After the last day of behavior testing, all animals were sacrificed and brain tissue was collected.
Histological analysis
In order to analyze the histological implications of the injection of aCSF or L-AA, we performed the immunohistochemical characterization of frozen coronal sections (20 μm thick) containing the mPFC of five CON and four L-AA animals that performed the ASST and six CON and eight L-AA animals that performed the water maze tests (for methodological details, see SI). Briefly, brain sections were stained for: GFAP (astrocytes; 1:200, DakoCytomation, Glostrup, Denmark), NeuN (neurons, 1:100, Millipore, Schwalbach, Germany) and DAPI (nuclei, 1:1000, Invitrogen, Paisley, UK); GFAP (astrocytes; 1:200, DakoCytomation), S100β (astrocytes, 1:100, Sigma, Taufkirchen, Germany) and DAPI (nuclei, 1:1000, Invitrogen); S100β (astrocytes, 1:100, Sigma) with 3,3-diaminobenzidine (DAB); GFAP (astrocytes; 1:200, DakoCytomation), Iba1 (microglia, 1:100, Abcam, Cambridge, UK) and DAPI (nuclei, 1:1000, Invitrogen). The effect of L-AA injection in the mPFC was evaluated by analyzing the numbers of GFAP-and NeuNpositive cells (to assess the effect on astrocytes and neurons, respectively) in the targeted region dorsal PrL/Cg1 (lesion site), and in the ventral PrL, (peri-lesion site; see results section) through confocal microscopy imaging (FV1000, Olympus, Hamburg, Germany) and ImageJ software (http:// rsbweb.nih.gov/ij/). The density of cells, given in number of cells per μm 2 , in lesion and peri-lesion sites was normalized to the density of cells in the infralimbic (IL-a neighbor unaffected area) of the same brain section. The resulting relative values allowed comparison between different animals excluding variation due to fluctuation of staining quality between sections.
To further understand the consequences of L-AA injection to neurons of the affected areas, their three-dimensional dendritic morphology was analyzed and compared to the site of aCSF infusion, in CON animals.
Neuronal structures were also analyzed in the IL region of animals in both groups to confirm that changes were restricted to the affected area. Briefly, the analysis was performed for ten neurons in each region for each animal group in coronal brain slices after Golgi-Cox impregnation. 59 Identification and reconstruction of Golgi-impregnated layer III pyramidal neurons in the mPFC and estimation of spine densities was performed as previously described. 59 Dendritic trees were reconstructed using a motorized microscope (Axioplan 2, Carl Zeiss, Göttingen, Germany) and Neurolucida/NeuroExplorer software (Microbrightfield, Williston, VT, USA). To assess structural changes, number of basal dendrites, total length and branches of basal and apical trees, as well as Sholl analysis 60,61 were compared across groups. For spine density analysis, dendritic segments of 30 μm were randomly selected in the proximal and distal portions of the apical dendrite and basal dendrites, and spines were classified in mushroom, thin, wide and ramified categories. For details on the histological procedures and neuronal reconstruction, see SI.
Statistical analysis
Data are expressed throughout the manuscript as means ± s.e.m. Statistical analysis was performed using the Prism 5 (GraphPad Software Inc., La Jolla, CA, USA). Unpaired t-test was applied to compare: dendritic length; number of branches or dendrites; total spine density. Two-way analysis of variance (ANOVA) analysis and Bonferroni post-hoc tests were applied to analyze: ASST and water maze task performances; cell counts between lesion and non-lesion sites; dendritic length or number of intersections of neurons in the Sholl analysis; densities of the four categories of spines. The statistical significance of the comparisons for each statistical test was set with a confidence interval of 95%.
RESULTS
The results presented in this section represent all animals on which the bilateral injections of aCSF (CON group) or L-α-aminoadipate (AA group) targeted the mPFC (Supplementary Figure S1 ; see histological results below). Therefore, the data herein presented enclose behavior outputs of seven CON and six AA animals that performed ASST, and six CON animals and eight AA that performed water maze tests.
Astrocyte pathology in the mPFC impairs the working memory and reversal learning functions of rats In order to assess the translation of astrocyte loss in the behavior output of the mPFC, animals injected with the toxin L-AA and their respective controls performed tasks dependent on the function of this region.
The ASST (Figure 1 ) assesses functions such as attention, dimensional set-shifting and reversal learning. 56 Both controls (CON) and treated animals (AA) animals learnt to discriminate the reward by odor in the first stage of the test since they display a similar number of trials to acquire the rule (trials to criterion, TC; simple discrimination by odor (SDO), t = 1.1, P>0.05). However, animals with astrocyte pathology in the mPFC (AA) displayed a striking difficulty in learning to discriminate stimuli in the dimension of textures simple discrimination by textures (SDT, t = 2.7, P o0.05) and to perform reversal learning (observed consistently across the stages; Rev 1: t = 3.0, P o 0.05; Rev 2, t = 3.8, P o 0.01), when compared to CON (Figure 1b) . No differences were observed between groups in the remaining stages (compound discrimination of odors (CDO), t = 0.2, P>0.05; or extra dimensional shift of textures (EDST), t = 0.7, P>0.05).
The water maze tests were performed to assess spatial working memory (WMT) and spatial reference memory (RMT) 58 in the animals with mPFC astrocyte pathology and respective controls. The analysis of the WMT learning curve showed that astrocyte depletion impaired consistently the working memory (Figure 2b ; F 1 , 12 = 5.07, P = 0.04), particularly in trial 4 (trial 1, t = 0.10, P>0.05; trial 2, t = 1.28, P>0.05; trial 3, t = 1.61, P>0.05; trial 4, t = 2.61, Po 0.05). In the spatial RMT, differences were observed in the learning curves (Figure 2e ; F 1 , 12 = 6.85, P = 0.03), mostly due to the acquisition difficulties faced by the AA animals. Differences in distance swam consistently supported the measurements of escape latencies both for WMT (Figure 2c ; F 1 , 12 = 8.44, P = 0.01) and RMT (Figure 2f ; F 1 , 12 = 9.93, P = 0.01).
L-AA-induced astrocyte pathology is characterized by depletion and neuronal damage in the region affected The preliminary analysis of the brain sections containing the mPFC of CON and AA animals selected for analysis revealed that the injections targeted specifically an area concerning the dorsal portion of the PrL and Cg1 sub-regions of the mPFC (Supplementary Figure  S1) . This observation was confirmed by the microscopic analysis of the brain sections stained with GFAP antibody, for AA animals. A fluorescence halo was observed in the sites where the bilateral injection of L-AA took place, on which the GFAP staining was completely absent (Figure 3a) . This observation was confirmed by immunostaining with S100β antibody that marked typical astrocyte morphologies, which were absent at lesion sites (Supplementary Figure S2) , confirming that L-AA injections lead to the ablation of astrocytes of both GFAP+ and S100B+ populations.
The double staining with astrocytic (GFAP) and neuronal (NeuN) markers revealed that despite the complete absence of astrocytes in the lesion site, neurons were easily observable within this area (Figures 3b and c) . The calculation of astrocyte relative densities in lesion areas (given by the number of GFAP+ astrocytes per unit of area, relatively to the density of astrocytes in the IL region of the same section) revealed astrocyte depletion in the L-AA-injected subjects, 2 days post injection (t = 11.92, P o0.001; Figure 3d ) and 6 days post injection (t = 8.0, P o 0.001; Figure 3e) , when compared to the respective aCSF-injected controls (for absolute values, see Supplementary Table S2) . Furthermore, the effects of L-AA were confined to the injection targets, since astrocyte numbers were not affected in the peri-lesion region from any of the tested animals (2 days post injection: t = 0.34, P>0.05; Figure 3f ; 6 days post injection: t = 0.57, P>0.05; Figure 3g ). Interestingly, the calculation of relative neuronal densities (given by the number of NeuN+ neurons per unit of area, relatively to the density of neurons in the IL region of the same section) revealed a 29.9% of neuronal loss in the sites of L-AA injection 2 days (t = 2.97, P o 0.05; Figure 3d) ; this loss was considerably higher 6 days post injection (44.8% of loss: t = 3.3, P o0.05; Figure 3e) , when compared to aCSF-injected controls (for absolute values, see Supplementary Table S2) . Again, this effect was restricted to the lesion site as in the vicinity of the lesion, the neuronal densities remained unaltered 2 days (t = 0.57, P>0.05; Figure 3f ) and 6 days post injection (t = 0.5, P>0.05; Figure 3g ).
The surgical procedure and injection of saline in control animals did not trigger microglial response, confirmed by the typical resting state morphology with small somas, and fine, long and ramified processes 62 observed at the targeted sites ( Supplementary Figures S3A and B) . The astrocyte toxin L-AA induced an activation of microglia characterized by alteration of the cell structure, reduction of process length towards an amoeboid structure, 62 which is visible at both 2 and 6 days post injection in the lesion sites (Supplementary Figures S3C and D) . These alterations are in line and may explain the structural changes observed in neurons and astrocytes. Regarding the functional consequence of microglial activation, we believe that it may have an impact on the overall activity of the network. However, due to the difficulty to tackle this implication and the controversy on the link between astrocyte loss and microglia activation in psychiatric disorders 63 this issue needs to be further addressed by other studies in the field.
3D neuronal structure in the mPFC is affected by the astrocyte pathology Regarding the analysis of the neuronal morphology (Figure 4 and Supplementary Figure S4) , neurons located at the lesion site of animals from CON and AA groups displayed a quite similar structure 2 days post injection (Figure 4a) . Specifically, there were no significant differences in apical dendritic length (t = 1.35 P>0.05), number of apical dendrite branches (t = 1.03, P>0.05), number of basal dendrite branches (t = 0.9, P>0.05) or number of basal dendrites (t = 0.62, P >0.05) (Figures 4a and Supplementary Figure S5A) ; however, a reduction in basal dendritic length was observed in AA-injected animals (t = 2.34, P o 0.05) (Figure 4a ). These observations were similar to those made in the peri-lesion area where no differences between CON and AA animals were observed in any of the parameters estimated (Figure 4c and Supplementary Figure S5C) .
Interestingly, the neuronal structure of AA animals in the lesioned areas 6 days post injection was severely affected when compared to CON animals ( Figure 4b and Supplementary Figure  S5B) . Layer III pyramidal neurons of those regions presented reduced apical dendritic length (t = 4.7, P o0.001) basal dendritic length (t = 6.3, Po 0.001; Figure 4b) . Interestingly, the number of basal dendrites in neurons in lesion areas of AA animals did not change when compared to the CON group (t = 0.8, P>0.05; Figure 4b ), which indicates that the reductions in length and branching observed represent atrophy of the existing dendrites, rather than general structure damage. Again, this effect was confined to the lesion area as confirmed by the analysis of 3D neuronal structures in the IL, a neighbor area spared from the L-AA injection effects. Here, no significant differences were found in any of the parameters estimated (Figure 4d and Supplementary Figure S5D ).
These observations were confirmed by the Sholl analysis that calculates both number of intersections and length of dendrites at specific distances from the soma (Figure 4 and Supplementary Figure S5 ) both for 2 and 6 days after the lesion. The reorganization of the dendritic material described above is visible in Figures 4a and b left panel (details in Supplementary Figure S4) , where representative 3D reconstructions are presented for illustration of treatment effects.
The categorization of spines and determination of its density in basal, apical proximal and apical distal segments of the reconstructed neurons provided a more detailed insight of the effects of astrocyte ablation to the neuronal integrity and function. The absence of astrocytes in targeted regions did not alter the density of spines in basal, apical proximal or apical distal dendritic portions. These observations were true for neurons located within lesion sites from animals 2 days post injection (Figure 5a ) and 6 days post injection (Figure 5b) . Accordingly, the total density of spines remained intact at peri-lesioned region (IL) as well, either 2 ( Figure 5c ) or 6 (Figure 5d ) days post injection, both in CON and AA groups. The discrimination and quantification of each spine type according to maturity criteria (thin, mushroom, ramified or wide) sustained these observations, since no differences were observed between groups for each spine type between lesion and peri-lesion areas whatsoever (Supplementary Figure S6) .
DISCUSSION
The first highlight of this study is the regional specificity of the lesion. In fact, the model used herein allowed to target specifically astrocytes within the mPFC, without signs of lesion in the surrounding areas, at least as indicated by the unaffected astrocytic densities observed at peri-lesion sites. Accordingly, neuronal loss or effects on the dendritic structure were confined to the regions where astrocyte loss occurred. Interestingly, both neuronal loss and dendritic atrophy were increasing with time after the injection of the astrocyte toxin L-AA. This observation was not described previously in similar studies, 51, 53, 55 a fact that could be ascribed to the technical differences between studies. Since L-AA is described to affect specifically astrocytes and to cause immediate astrocyte loss in the targeted region, 51 ,53,55 a finding herein confirmed after 2 days of lesion, these pieces of evidence suggest that neuronal damage is as a consequence of the astrocyte loss in the targeted region. In this context of astrocyte pathology, neuronal damage may occur due to the lack of extracellular space homeostasis, excitatory neurotransmitter uptake and metabolic support functions largely attributed to astrocytes that are responsible for the neuronal nourishing, maintenance and survival. 1, 2 In particular, lack of astrocytic buffering of extracellular excitatory neurotransmitter glutamate was shown to induce dendritic atrophy 64 and neuronal death through excitotoxicity, [65] [66] [67] that are similar to the effects observed in this model of astrocyte pathology.
Typically the L-AA-induced loss of astrocytes targeted the dorsal portion of the prelimbic, as well as the cingulate subregions of the mPFC. The function of the mPFC was tested using behavior tasks that rely on this area to assess the impact of the astrocyte pathology and consequent neuronal damage in the computation of cognitive outputs. Astrocyte pathology in the mPFC affects the attentional set-shifting, the working memory and the reversal learning functions. The attentional set-shifting, defined as the capability to 'unlearn' an established contingency in order to learn a new one by shifting the attention from previously irrelevant one to previously salient stimulus is computed by the mPFC in rodents 56 and primates. 68, 69 AA animals showed increased difficulty when learning to discriminate the reward pot when indicated by textures in the transition from SDO to SDT stage. This shift of stimuli dimensions-from odor to texture-was shown to be dependent on the intact function of the prelimbic cortex, 70 which, in these animals, was targeted by the L-AA injections. In addition, astrocyte pathology caused a worse performance in the reversal learning stages, which was already described to arise after lesions in the mPFC 71 and might be due to an impairment in the ability to attend relevant stimuli features within the same dimension. 72 These observations are consistent with the critical role displayed by mPFC in shifting to new strategies or rules. [73] [74] [75] [76] When tested in water maze tasks, AA animals displayed impaired working memory, which is a cognitive function dependent on the mPFC. 76 Altogether, these behavior data indicate that the astrocyte pathology is sufficient to induce an impairment of the mPFC function. On the basis of the description of similar performances in previous neuronal lesion studies, 56, 70, 77 this evidence suggests that the behavior impairments observed may be caused mainly by an indirect neuronal degeneration as a consequence of the initial affection of neighbor astrocytes. Until now, we have implicated the poorer performance of the mPFC in the compromised neuronal function as a consequence of surrounding astrocyte pathology, which leads to failure in metabolic supply to neurons, 78,79 homeostasis of K + and H + ions 3 and neurotransmitters. 1, 2, 79, 80 We should, however, stress that besides these functions, astrocytes are also implicated in the modulation of the synaptic transmission and integration of neuron-glia circuits. [5] [6] [7] Although this model is not adequate to assess specifically the function of the tripartite synapse, 5 results presented here indicate a crucial impairment of the network output. As there is still a large group of resilient neurons in the mPFC, we suggest that the lack of astrocytic surveillance in the mPFC synaptic connections may account for network dysfunction and consecutive deficient behavior output.
This study strongly supports the view that astrocytes, targeted in a pathological process, may lead to neurodegeneration in a specific brain region. In the case of mood disorders such as depression or bipolar disorder reported in the literature with impact on cognitive function, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] the changes of astrocytes within the PFC may underlie the cognitive dysfunction observed in these patients.
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